Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 602,562 | 570,721 | 514,542 | 759,598 | 581,889 |
| Marketable Securities | 620,167 | 1,134,989 | 1,176,115 | 448,146 | 681,835 |
| Receivables | 824,406 | 686,848 | 584,603 | 605,329 | 551,208 |
| Inventories | 659,003 | 447,373 | 326,843 | 289,066 | 293,950 |
| Other current assets | 478,796 | 404,406 | 373,324 | 438,281 | 371,713 |
| TOTAL | $3,184,934 | $3,244,337 | $2,975,427 | $2,540,420 | $2,480,595 |
| Non-Current Assets | |||||
| PPE Net | 1,750,710 | 1,742,200 | 1,571,387 | 1,641,634 | 1,637,083 |
| Investments And Advances | 1,220,122 | 2,310,712 | 1,748,285 | 991,299 | 1,424,477 |
| Intangibles | 5,707,569 | 2,832,843 | 2,754,505 | 2,919,140 | 3,009,699 |
| Other Non-Current Assets | -1 | 0 | 0 | 0 | 0 |
| TOTAL | $8,678,400 | $6,885,755 | $6,074,177 | $5,552,073 | $6,071,259 |
| Total Assets | $11,863,330 | $10,130,120 | $9,049,604 | $8,092,493 | $8,551,854 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 219,913 | 203,999 | 186,448 | 162,529 | 118,534 |
| Accrued Expenses | 1,355,187 | 979,945 | 677,210 | 665,923 | 500,755 |
| TOTAL | $1,758,279 | $1,657,389 | $912,889 | $1,050,122 | $714,942 |
| Non-Current Liabilities | |||||
| Long Term Debt | 592,433 | 687,396 | 1,060,808 | 1,066,379 | 1,080,207 |
| aiOther Non-Current Liabilities | 659,231 | 604,266 | 368,018 | 432,299 | 247,275 |
| TOTAL | $1,484,218 | $1,508,934 | $1,709,728 | $1,592,928 | $1,575,030 |
| Total Liabilities | $3,242,497 | $3,166,323 | $2,622,617 | $2,643,050 | $2,289,972 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 236,000 | 236,312 | 238,725 | 240,912 | 269,601 |
| Common Shares | 128 | 127 | 128 | 124 | 144 |
| Retained earnings | 6,349,135 | 4,486,794 | 3,106,761 | 1,872,481 | 1,068,890 |
| Other shareholders' equity | -27,076 | -52,651 | -24,950 | 31,735 | 90,928 |
| TOTAL | $8,620,838 | $6,963,795 | $6,426,987 | $5,449,443 | $6,261,882 |
| Total Liabilities And Equity | $11,863,335 | $10,130,118 | $9,049,604 | $8,092,493 | $8,551,854 |